8-K
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001213900-20-004829
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading ea119058-8k_elitepharma.htm…